Italia markets open in 5 hours 16 minutes
Dow Jones
38.686,32 +574,82 (+1,51%) Nasdaq
16.735,02 -2,08 (-0,01%) Nikkei 225
38.907,09 +419,19 (+1,09%) EUR/USD
1,0860 +0,0006 (+0,05%) Bitcoin EUR
62.841,99 +428,95 (+0,69%) CMC Crypto 200
1.474,20 +45,63 (+3,19%)
NVCR Jun 2024 25.000 call
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
In data: 12:02PM EDT. Mercato aperto.
| Chiusura precedente | 0,5000 |
| Aperto | 0,5300 |
| Denaro | 0,3000 |
| Domanda | 0,7000 |
| Prezzo d'esercizio | 25,00 |
| Scadenza | 2024-06-21 |
| Min-Max giorno | 0,5300 - 0,7000 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 1,8k |
GlobeNewswireZai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in
© 2024 Yahoo. Tutti i diritti riservati.